Suppr超能文献

肾微血管对乙酰胆碱反应的决定因素:内皮衍生超极化因子对入球和出球小动脉的作用

Determinants of renal microvascular response to ACh: afferent and efferent arteriolar actions of EDHF.

作者信息

Wang Xuemei, Loutzenhiser Rodger

机构信息

Smooth Muscle Research Group, Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada.

出版信息

Am J Physiol Renal Physiol. 2002 Jan;282(1):F124-32. doi: 10.1152/ajprenal.0157.2001. Epub 2003 Mar 11.

Abstract

The renal microvascular actions of ACh were investigated using the in vitro perfused hydronephrotic rat kidney. ACh reversed ANG II-induced vasoconstriction in the afferent and efferent arteriole by 106 +/- 2 and 75 +/- 5%, respectively. Inhibition of nitric oxide synthase [NOS; 100 micromol/l N(G)-nitro-L-arginine methyl ester (L-NAME)] and cyclooxygenase (COX; 10 micromol/l ibuprofen) prevented the sustained response of the afferent arteriole but did not reduce the magnitude of the initial dilation (97 +/- 7%). However, NOS/COX inhibition abolished the response of the efferent arteriole. The underlying mechanisms mediating this endothelium-derived hyperpolarizing factor (EDHF)-like response were characterized using K channel blockers. Ba (100 micromol/l), tetraethylammonium (1 mmol/l), and ouabain (3 mmol/l) had no effect, arguing against a role of an inward rectifier K channel, large-conductance Ca-activated K channel, or Na,K-ATPase. Charybdotoxin (10 nmol/l) and apamin (1.0micromol/l) attenuated the response when administered alone (63 +/- 7% and 37 +/- 5%, respectively) and abolished the response when coadministered (0.1 +/- 1.0%). These findings indicate that, as in other vascular beds, the renal EDHF-like response to ACh involves K channels that are sensitive to a combination of apamin and charybdotoxin. Our finding that EDHF modulates preglomerular, but not postglomerular, tone is consistent with the evolving concept that vasomotor mechanisms in cortical efferent arterioles do not involve voltage-gated Ca entry.

摘要

使用体外灌注的肾积水大鼠肾脏研究了乙酰胆碱(ACh)对肾微血管的作用。ACh分别使血管紧张素II(ANG II)诱导的入球小动脉和出球小动脉血管收缩逆转了106±2%和75±5%。抑制一氧化氮合酶[NOS;100 μmol/L N(G)-硝基-L-精氨酸甲酯(L-NAME)]和环氧化酶(COX;10 μmol/L布洛芬)可阻止入球小动脉的持续反应,但不降低初始扩张幅度(97±7%)。然而,抑制NOS/COX消除了出球小动脉的反应。使用钾通道阻滞剂对介导这种内皮源性超极化因子(EDHF)样反应的潜在机制进行了表征。钡(100 μmol/L)、四乙铵(1 mmol/L)和哇巴因(3 mmol/L)无作用,这表明内向整流钾通道、大电导钙激活钾通道或钠钾ATP酶不起作用。单独给予蝎毒素(10 nmol/L)和蜂毒明肽(1.0 μmol/L)时,反应减弱(分别为63±7%和37±5%),联合给予时反应消除(0.1±1.0%)。这些发现表明,与其他血管床一样,肾脏对ACh的EDHF样反应涉及对蜂毒明肽和蝎毒素组合敏感的钾通道。我们发现EDHF调节肾小球前而非肾小球后的张力,这与皮质出球小动脉的血管运动机制不涉及电压门控钙内流这一不断发展的概念一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验